Familial Hypercholesterolaemia
(asked on 23rd March 2017) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, if he will estimate the potential (a) medium and (b) long-term cost savings to the NHS of the use of genetic cascade testing to identify and treat familial hypercholesterolaemia.
This question was answered on 30th March 2017
The current National Institute for Health and Care Excellence guidance recommends genetic cascade testing for familial hypercholesterolaemia as highly cost effective. This guidance is currently under review, due to be issued in May 2017, and will take into account the latest changes to the costs of drugs and genetic tests in its revised economic modelling.